Table 2 Comparison between scleroderma patients with and without enthesitis detected by ultrasound regarding demographic, clinical, and laboratory data
Scleroderma patients, n = 40 | ||||
|---|---|---|---|---|
Parameter | All (n = 40) | Pt. with enthesitis (n = 25) | Pt. without enthesitis (n = 15) | Sig. |
Age (years) | 42.44 ± 7.34 | 41.32 ± 6.32 | 43.56 ± 8.36 | 0.312 |
Sex (female) | 20 (100.0%) | 13 (100%) | 7 (100%) | 1.000 |
Disease duration (years) | 9.79 ± 4.39 | 10.20 ± 4.28 | 9.38 ± 4.49 | 0.535 |
MASEI | 16.32 ± 7.27 | 18.56 ± 4.08 | 10.20 ± 4.20 | < 0.001** |
Clinical manifestations | ||||
 LcSSc | 21 (52.5%) | 7 (28%) | 14 (93.3%) | < 0.001** |
 DcSSc | 19 (47.5%) | 18 (72%) | 1 (6.7%) | < 0.001** |
 Raynaud’s | 25 (62.5%) | 15 (60.0%) | 10 (66.7%) | 0.676 |
 IPF | 27 (67.5%) | 22 (88.0%) | 5 (33.3%) | < 0.001** |
 Digital ulcer | 21 (52.5%) | 19 (76.0%) | 2 (13.3%) | < 0.001** |
 Pulmonary hypertension | 15 (37.5%) | 11 (44.0%) | 4 (26.7%) | < 0.001** |
 Telangiectasia | 8 (20.0%) | 6 (24.0%) | 2 (13.3%) | 0.419 |
 Esophageal dysmobility | 33 (82.5%) | 21 (84.0%) | 12 (80.0%) | 0.750 |
 Arthritis/arthralgia | 24 (60.0%) | 20 (80.0%) | 4 (26.7%) | < 0.001** |
Laboratory investigations | ||||
 Hemoglobin (g/dl) | 11.30 ± 2.32 | 10.81 ± 2.22 | 11.78 ± 2.40 | 0.167 |
 WBC (109/l) | 7.57 ± 2.73 | 7.24 ± 2.55 | 7.89 ± 2.91 | 0.429 |
 Platelets (109/l) | 268.72 ± 61.23 | 257.14 ± 57.22 | 280.29 ± 65.23 | 0.212 |
 ESR (mm/1st h) | 39.22 ± 13.77 | 57.83 ± 15.71 | 20.60 ± 11.83 | < 0.001** |
Nailfold capillary pattern | ||||
 Early pattern | 4 (10.0%) | 1 (4%) | 3 (20%) | 0.107 |
 Active | 13 (32.5%) | 8 (32%) | 5 (33.3%) | 0.933 |
 Late | 19 (47.5%) | 16 (64%) | 3 (20%) | 0.008* |
 Normal pattern | 4 (10.0%) | 0 (0.0%) | 4 (26.7%) | 0.007* |